Association between non-alcoholic fatty liver disease and coronary artery disease outcomes: A systematic review and meta-analysis.

ABSTRACT

OBJECTIVES: To evaluate the association between non-alcoholic fatty liver disease (NAFLD) and cardiovascular outcomes, including angina, coronary artery disease (CAD), coronary artery calcification (CAC), myocardial infarction (MI), and calcified coronary plaques. METHODS: A comprehensive search of databases, including PubMed, EMBASE, and Cochrane Library, was conducted up to January 2023. Studies were included investigating the relationship between NAFLD and cardiovascular outcomes in adult populations. Exclusion criteria were studies on animals, pediatric populations, and those not published in English. Two reviewers assessed the risk of bias in the included studies using the Newcastle-Ottawa Scale. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using random-effects models. RESULTS: The meta-analysis included 32 studies with a total of 5,610,990 participants. NAFLD demonstrated significant associations with increased risks of angina (Relative Risk (RR) 1.45, 95% CI 1.17, 1.79), CAD (RR 1.21, 95% CI 1.07, 1.38), CAC >0 (RR 1.39, 95% CI 1.15, 1.69), and calcified coronary plaques (RR 1.55, 95% CI 1.05, 2.27). However, no significant association was found between NAFLD and CAC >100 (RR 1.16, 95% CI 0.97, 1.38) or MI (RR 1.70, 95% CI 0.16, 18.32). CONCLUSION: The meta-analysis demonstrated a significant association between NAFLD and cardiovascular outcomes independent of conventional cardiovascular disease (CVD) risk factors. These findings emphasize the importance of prevention, early detection, and proper management of NAFLD.